グローバル性交困難症の治療薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】
Dyspareunia Drugs - Global Top Players Market Share and Ranking 2026
- レポートID：223999
- 発表時期：2026-03-03
- レポート形式：PDF
- 産業カテゴリー：薬品及びサプリメント
- レポート言語：英語、日本語
- ページ数：95
- 発行会社（調査会社）：YHResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。
※米ドル表示価格+10％消費税。
※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界の性交困難症の治療薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から性交困難症の治療薬市場を分析し、需要構造と成長特性を明確化します。
性交困難症の治療薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、性交困難症の治療薬に関する的確な意思決定を行うための実践的なインサイトを提供します。
主要性交困難症の治療薬市場の統計
2025年世界市場規模：836百万米ドル
2026年世界市場規模：866百万米ドル
2032年予測市場規模：1087百万米ドル
2026–2032年予測期間CAGR：3.8%
本レポートは性交困難症の治療薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
性交困難症の治療薬市場の主要企業には以下が含まれます：
Pfizer
Therapeutics MD
Myovant
Novo Nordisk
Duchesnay USA Inc
Maynepharma
Manus Aktteva Biopharma LLP
Lupin Pharma Canada
Verity Pharma
Teva Pharmaceuticals
製品別
Oral
Vaginal Insert
アプリケーション別
Hospital
Clinic
Others
レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他
レポート構成（章別概要）
第1章｜市場概要と成長展望
性交困難症の治療薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
性交困難症の治療薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に性交困難症の治療薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に性交困難症の治療薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、性交困難症の治療薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、性交困難症の治療薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
性交困難症の治療薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
性交困難症の治療薬市場の全体像と成長見通し
性交困難症の治療薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が性交困難症の治療薬市場に与える影響を分析いたします
市場環境の構成要素とマクロトレンド
性交困難症の治療薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
競争構造と主要企業の動向分析
性交困難症の治療薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から性交困難症の治療薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
成長要因・課題・リスクの分析
性交困難症の治療薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
将来トレンドと市場展望
性交困難症の治療薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
Description
According to YH Research, the global market for Dyspareunia Drugs should grow from US$ 836 million in 2025 to US$ 1087 million by 2032, with a CAGR of 3.8% for the period of 2026-2032.
Dyspareunia is a medical term that refers to pain experienced during or after sexual intercourse. It can affect both men and women, but it is more commonly reported by women. The pain may be superficial or deep, and it can vary in intensity.
There is an increasing focus on developing drugs that target specific molecular pathways or physiological mechanisms associated with dyspareunia. This approach aims to enhance the efficacy of treatment while minimizing side effects.
This report studies and analyses global Dyspareunia Drugs status and future trends, to help determine the Dyspareunia Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Dyspareunia Drugs, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Dyspareunia Drugs market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Dyspareunia Drugs by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Dyspareunia Drugs by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Dyspareunia Drugs key consuming regions, consumption value and demand structure
(5) Dyspareunia Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer
Therapeutics MD
Myovant
Novo Nordisk
Duchesnay USA Inc
Maynepharma
Manus Aktteva Biopharma LLP
Lupin Pharma Canada
Verity Pharma
Teva Pharmaceuticals
Market segment by Type, covers
Oral
Vaginal Insert
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Dyspareunia Drugs product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Dyspareunia Drugs market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Dyspareunia Drugs market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Dyspareunia Drugs industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
Table of Contents
1 Market Overview
1.1 Dyspareunia Drugs Definition
1.2 Global Dyspareunia Drugs Market Size and Forecast
1.3 Japan Dyspareunia Drugs Market Size and Forecast
1.4 Share of Japan Dyspareunia Drugs Market with Respect to the Global Market
1.5 Dyspareunia Drugs Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Dyspareunia Drugs Market Dynamics
1.6.1 Dyspareunia Drugs Market Drivers
1.6.2 Dyspareunia Drugs Market Restraints
1.6.3 Dyspareunia Drugs Industry Trends
1.6.4 Dyspareunia Drugs Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Dyspareunia Drugs, Global Market Share by Company, 2021-2026
2.2 Global Dyspareunia Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Dyspareunia Drugs Concentration Ratio
2.4 Global Dyspareunia Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global Dyspareunia Drugs Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Dyspareunia Drugs, Japan Market Share by Company, 2021-2026
3.2 Japan Dyspareunia Drugs Dyspareunia Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Dyspareunia Drugs Industry Chain
4.2 Dyspareunia Drugs Upstream Analysis
4.2.1 Dyspareunia Drugs Core Raw Materials
4.2.2 Main Manufacturers of Dyspareunia Drugs Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Dyspareunia Drugs Production Mode
4.6 Dyspareunia Drugs Procurement Model
4.7 Dyspareunia Drugs Industry Sales Model and Sales Channels
4.7.1 Dyspareunia Drugs Sales Model
4.7.2 Dyspareunia Drugs Typical Distributors
5 Sights by Type
5.1 Dyspareunia Drugs Classification by Type
5.1.1 Oral
5.1.2 Vaginal Insert
5.2 by Type, Global Dyspareunia Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Dyspareunia Drugs Consumption Value, 2021-2032
6 Sights by Application
6.1 Dyspareunia Drugs Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.1.3 Others
6.2 by Application, Global Dyspareunia Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Dyspareunia Drugs Consumption Value, 2021-2032
7 Sales Sights by Region
7.1 By Region, Global Dyspareunia Drugs Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Dyspareunia Drugs Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Dyspareunia Drugs Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Dyspareunia Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe Dyspareunia Drugs Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Dyspareunia Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Dyspareunia Drugs Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Dyspareunia Drugs Market Size Market Share
7.6 South America
7.6.1 South AmericaDyspareunia Drugs Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Dyspareunia Drugs Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Dyspareunia Drugs Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Dyspareunia Drugs Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Dyspareunia Drugs Market Size, 2021-2032
8.3.2 by Type, United States Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Dyspareunia Drugs Market Size, 2021-2032
8.4.2 by Type, Europe Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Dyspareunia Drugs Market Size, 2021-2032
8.5.2 by Type, China Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Dyspareunia Drugs Market Size, 2021-2032
8.6.2 by Type, Japan Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Dyspareunia Drugs Market Size, 2021-2032
8.7.2 by Type, South Korea Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Dyspareunia Drugs Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Dyspareunia Drugs Market Size, 2021-2032
8.9.2 by Type, India Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Dyspareunia Drugs Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032
9 Company Profile
9.1 Pfizer
9.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
9.1.2 Pfizer Company Profile and Main Business
9.1.3 Pfizer Dyspareunia Drugs Models, Specifications, and Application
9.1.4 Pfizer Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.1.5 Pfizer Recent Developments
9.2 Therapeutics MD
9.2.1 Therapeutics MD Company Information, Head Office, Market Area, and Industry Position
9.2.2 Therapeutics MD Company Profile and Main Business
9.2.3 Therapeutics MD Dyspareunia Drugs Models, Specifications, and Application
9.2.4 Therapeutics MD Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.2.5 Therapeutics MD Recent Developments
9.3 Myovant
9.3.1 Myovant Company Information, Head Office, Market Area, and Industry Position
9.3.2 Myovant Company Profile and Main Business
9.3.3 Myovant Dyspareunia Drugs Models, Specifications, and Application
9.3.4 Myovant Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.3.5 Myovant Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
9.4.2 Novo Nordisk Company Profile and Main Business
9.4.3 Novo Nordisk Dyspareunia Drugs Models, Specifications, and Application
9.4.4 Novo Nordisk Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.4.5 Novo Nordisk Recent Developments
9.5 Duchesnay USA Inc
9.5.1 Duchesnay USA Inc Company Information, Head Office, Market Area, and Industry Position
9.5.2 Duchesnay USA Inc Company Profile and Main Business
9.5.3 Duchesnay USA Inc Dyspareunia Drugs Models, Specifications, and Application
9.5.4 Duchesnay USA Inc Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.5.5 Duchesnay USA Inc Recent Developments
9.6 Maynepharma
9.6.1 Maynepharma Company Information, Head Office, Market Area, and Industry Position
9.6.2 Maynepharma Company Profile and Main Business
9.6.3 Maynepharma Dyspareunia Drugs Models, Specifications, and Application
9.6.4 Maynepharma Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.6.5 Maynepharma Recent Developments
9.7 Manus Aktteva Biopharma LLP
9.7.1 Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area, and Industry Position
9.7.2 Manus Aktteva Biopharma LLP Company Profile and Main Business
9.7.3 Manus Aktteva Biopharma LLP Dyspareunia Drugs Models, Specifications, and Application
9.7.4 Manus Aktteva Biopharma LLP Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.7.5 Manus Aktteva Biopharma LLP Recent Developments
9.8 Lupin Pharma Canada
9.8.1 Lupin Pharma Canada Company Information, Head Office, Market Area, and Industry Position
9.8.2 Lupin Pharma Canada Company Profile and Main Business
9.8.3 Lupin Pharma Canada Dyspareunia Drugs Models, Specifications, and Application
9.8.4 Lupin Pharma Canada Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.8.5 Lupin Pharma Canada Recent Developments
9.9 Verity Pharma
9.9.1 Verity Pharma Company Information, Head Office, Market Area, and Industry Position
9.9.2 Verity Pharma Company Profile and Main Business
9.9.3 Verity Pharma Dyspareunia Drugs Models, Specifications, and Application
9.9.4 Verity Pharma Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.9.5 Verity Pharma Recent Developments
9.10 Teva Pharmaceuticals
9.10.1 Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
9.10.2 Teva Pharmaceuticals Company Profile and Main Business
9.10.3 Teva Pharmaceuticals Dyspareunia Drugs Models, Specifications, and Application
9.10.4 Teva Pharmaceuticals Dyspareunia Drugs Revenue and Gross Margin, 2021-2026
9.10.5 Teva Pharmaceuticals Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table of Figures
List of Tables Table 1. Dyspareunia Drugs Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million Table 2. Dyspareunia Drugs Market Restraints Table 3. Dyspareunia Drugs Market Trends Table 4. Dyspareunia Drugs Industry Policy Table 5. Global Dyspareunia Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 6. Global Dyspareunia Drugs Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 7. Global Dyspareunia Drugs Manufacturers Market Concentration Ratio (CR3 and HHI) Table 8. Global Dyspareunia Drugs Mergers & Acquisitions, Expansion Plans Table 9. Global Dyspareunia Drugs Major Companies Product Type Table 10. Head Office and Area Served of Key Players Table 11. Japan Dyspareunia Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 12. Japan Dyspareunia Drugs Revenue Market Share by Company, 2021-2026 Table 13. Global Key Players of Dyspareunia Drugs Upstream (Raw Materials) Table 14. Global Dyspareunia Drugs Typical Customers Table 15. Dyspareunia Drugs Typical Distributors Table 16. by Type, Global Dyspareunia Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 17. by Application, Global Dyspareunia Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 18. By Region, Global Dyspareunia Drugs Consumption Value, 2021 VS 2025 VS 2032, US$ Million Table 19. By Region, Global Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Table 20. By Country, Global Dyspareunia Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 21. By Country, Global Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Table 22. By Country, Global Dyspareunia Drugs Consumption Value Market Share, 2021-2032 Table 23. Pfizer Company Information, Head Office, Market Area, and Industry Position Table 24. Pfizer Company Profile and Main Business Table 25. Pfizer Dyspareunia Drugs Models, Specifications, and Application Table 26. Pfizer Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 27. Pfizer Recent Developments Table 28. Therapeutics MD Company Information, Head Office, Market Area, and Industry Position Table 29. Therapeutics MD Company Profile and Main Business Table 30. Therapeutics MD Dyspareunia Drugs Models, Specifications, and Application Table 31. Therapeutics MD Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 32. Therapeutics MD Recent Developments Table 33. Myovant Company Information, Head Office, Market Area, and Industry Position Table 34. Myovant Company Profile and Main Business Table 35. Myovant Dyspareunia Drugs Models, Specifications, and Application Table 36. Myovant Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 37. Myovant Recent Developments Table 38. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position Table 39. Novo Nordisk Company Profile and Main Business Table 40. Novo Nordisk Dyspareunia Drugs Models, Specifications, and Application Table 41. Novo Nordisk Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 42. Novo Nordisk Recent Developments Table 43. Duchesnay USA Inc Company Information, Head Office, Market Area, and Industry Position Table 44. Duchesnay USA Inc Company Profile and Main Business Table 45. Duchesnay USA Inc Dyspareunia Drugs Models, Specifications, and Application Table 46. Duchesnay USA Inc Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 47. Duchesnay USA Inc Recent Developments Table 48. Maynepharma Company Information, Head Office, Market Area, and Industry Position Table 49. Maynepharma Company Profile and Main Business Table 50. Maynepharma Dyspareunia Drugs Models, Specifications, and Application Table 51. Maynepharma Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 52. Maynepharma Recent Developments Table 53. Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area, and Industry Position Table 54. Manus Aktteva Biopharma LLP Company Profile and Main Business Table 55. Manus Aktteva Biopharma LLP Dyspareunia Drugs Models, Specifications, and Application Table 56. Manus Aktteva Biopharma LLP Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 57. Manus Aktteva Biopharma LLP Recent Developments Table 58. Lupin Pharma Canada Company Information, Head Office, Market Area, and Industry Position Table 59. Lupin Pharma Canada Company Profile and Main Business Table 60. Lupin Pharma Canada Dyspareunia Drugs Models, Specifications, and Application Table 61. Lupin Pharma Canada Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 62. Lupin Pharma Canada Recent Developments Table 63. Verity Pharma Company Information, Head Office, Market Area, and Industry Position Table 64. Verity Pharma Company Profile and Main Business Table 65. Verity Pharma Dyspareunia Drugs Models, Specifications, and Application Table 66. Verity Pharma Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 67. Verity Pharma Recent Developments Table 68. Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position Table 69. Teva Pharmaceuticals Company Profile and Main Business Table 70. Teva Pharmaceuticals Dyspareunia Drugs Models, Specifications, and Application Table 71. Teva Pharmaceuticals Dyspareunia Drugs Revenue and Gross Margin, US$ Million, 2021-2026 Table 72. Teva Pharmaceuticals Recent Developments List of Figures Figure 1. Dyspareunia Drugs Picture Figure 2. Global Dyspareunia Drugs Consumption Value, (US$ million) & (2021-2032) Figure 3. Japan Dyspareunia Drugs Consumption Value, (US$ million) & (2021-2032) Figure 4. By Consumption Value, Japan Dyspareunia Drugs Market Share of Global, 2021-2032 Figure 5. Global Dyspareunia Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025 Figure 6. Japan Dyspareunia Drugs Key Participants, Market Share, 2025 Figure 7. Dyspareunia Drugs Industry Chain Figure 8. Dyspareunia Drugs Procurement Model Figure 9. Dyspareunia Drugs Sales Model Figure 10. Dyspareunia Drugs Sales Channels, Direct Sales, and Distribution Figure 11. Oral Figure 12. Vaginal Insert Figure 13. by Type, Global Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 14. by Type, Global Dyspareunia Drugs Consumption Value Market Share, 2021-2032 Figure 15. Hospital Figure 16. Clinic Figure 17. Others Figure 18. by Application, Global Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 19. by Application, Global Dyspareunia Drugs Revenue Market Share, 2021-2032 Figure 20. By Region, Global Dyspareunia Drugs Consumption Value Market Share, 2021-2032 Figure 21. North America Dyspareunia Drugs Consumption Value & Forecasts, 2021-2032, US$ Million Figure 22. By Country, North America Dyspareunia Drugs Consumption Value Market Share, 2025 Figure 23. Europe Dyspareunia Drugs Consumption Value & Forecasts, 2021-2032, US$ Million Figure 24. By Country, Europe Dyspareunia Drugs Consumption Value Market Share, 2025 Figure 25. Asia Pacific Dyspareunia Drugs Consumption Value & Forecasts, 2021-2032, US$ Million Figure 26. By Country/Region, Asia Pacific Dyspareunia Drugs Consumption Value Market Share, 2025 Figure 27. South America Dyspareunia Drugs Consumption Value & Forecasts, 2021-2032, US$ Million Figure 28. By Country, South America Dyspareunia Drugs Consumption Value Market Share, 2025 Figure 29. Middle East & Africa Dyspareunia Drugs Consumption Value & Forecasts, 2021-2032, US$ Million Figure 30. United States Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 31. by Type, United States Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 32. by Application, United States Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 33. Europe Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 34. by Type, Europe Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 35. by Application, Europe Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 36. China Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 37. by Type, China Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 38. by Application, China Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 39. Japan Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 40. by Type, Japan Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 41. by Application, Japan Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 42. South Korea Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 43. by Type, South Korea Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 44. by Application, South Korea Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 45. Southeast Asia Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 46. by Type, Southeast Asia Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 47. by Application, Southeast Asia Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 48. India Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 49. by Type, India Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 50. by Application, India Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 51. Middle East & Africa Dyspareunia Drugs Consumption Value, 2021-2032, US$ Million Figure 52. by Type, Middle East & Africa Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 53. by Application, Middle East & Africa Dyspareunia Drugs Consumption Value Market Share, 2025 VS 2032 Figure 54. Research Methodology Figure 55. Breakdown of Primary Interviews Figure 56. Bottom-up Approaches Figure 57. Top-down Approaches
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>
当社から購入のメリット
多言語（英語、日本語）のサンプル提供
プロフェッショナルな日本語翻訳を提供
請求書、クレジットカードでのお支払いが可能です
必要なチャプターやカスタマイズされたレポートの注文が可能
購入後、アナリストに直接連絡することができます
購入方法
必要な言語とバージョンのレポート選択
レポート要件と見積もり依頼
電子メールによる注文
レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）
クレジットカード決済、オフライン振込に対応（後払い可）
クライアント様（例）
050-5840-2692 日本
0081-50-5840-2692 グローバル
info@globalreports.jp